Recital 1, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

On 20 October 2023, the European Commission received notification of a proposed

concentration pursuant to Article 4 of the Merger Regulation (EC) No 139/2004, by which Novozymes A/S (“Novozymes”) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Chr. Hansen Holding A/S (“Chr. Hansen” and together the “Parties” and the “Transaction”). 3 1 OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology of the TFEU will be used throughout this decision. 2 OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’). 3 Publication in the Official Journal of the European Union, OJ C, C/2023/599, 31.10.2023.

In the published version of this decision, some information has been omitted pursuant to Article 17(2) of Council Regulation (EC) No 139/2004 concerning non-disclosure of business secrets and other confidential information. The omissions are shown thus […]. Where possible the information omitted has been replaced by ranges of figures or a general description.